Authors:
Engelsman, M
Remeijer, P
van Herk, M
Lebesque, JV
Mijnheer, BJ
Damen, EMF
Citation: M. Engelsman et al., Field size reduction enables ISO-NTCP escalation of tumor control probability for irradiation of lung tumors, INT J RAD O, 51(5), 2001, pp. 1290-1298
Authors:
Damen, EMF
Brugmans, MJP
van der Horst, A
Bos, L
Lebesque, JV
Mijnheer, BJ
McShan, DL
Fraass, BA
Kessler, ML
Citation: Emf. Damen et al., Planning, computer optimization, and dosimetric verification of a segmented irradiation technique for prostate cancer, INT J RAD O, 49(4), 2001, pp. 1183-1195
Authors:
Theuws, JCM
Seppenwoolde, Y
Kwa, SLS
Boersma, LJ
Damen, EMF
Baas, P
Muller, SH
Lebesque, JV
Citation: Jcm. Theuws et al., Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer, INT J RAD O, 47(5), 2000, pp. 1201-1208
Authors:
van Herk, M
Remeijer, P
Rasch, C
Lebesque, JV
Citation: M. Van Herk et al., The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy, INT J RAD O, 47(4), 2000, pp. 1121-1135
Citation: Jcm. Theuws et al., Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer, INT J RAD O, 47(3), 2000, pp. 681-690
Authors:
Remeijer, P
Geerlof, E
Ploeger, L
Gilhuijs, K
van Herk, M
Lebesque, JV
Citation: P. Remeijer et al., 3-D portal image analysis in clinical practice: An evaluation of 2-D and 3-D analysis techniques as applied to 30 prostate cancer patients, INT J RAD O, 46(5), 2000, pp. 1281-1290
Authors:
Meijer, GJ
Bruinvis, IAD
Mijnheer, BJ
Lebesque, JV
Citation: Gj. Meijer et al., A treatment planning method to correct dose distributions distorted by setup verification fields, INT J RAD O, 46(5), 2000, pp. 1319-1328
Citation: Fjp. Hoebers et al., Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes, CANCER, 88(7), 2000, pp. 1633-1642
Authors:
Theuws, JCM
Muller, SH
Seppenwoolde, Y
Kwa, SLS
Boersma, LJ
Hart, GAM
Baas, P
Lebesque, JV
Citation: Jcm. Theuws et al., Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study, J CL ONCOL, 17(10), 1999, pp. 3091-3100
Authors:
Rasch, C
Remeijer, P
Koper, PCM
Meijer, GJ
Stroom, JC
Van Herk, M
Lebesque, JV
Citation: C. Rasch et al., Comparison of prostate cancer treatment in two institutions: A quality control study, INT J RAD O, 45(4), 1999, pp. 1055-1062
Authors:
Meijer, GJ
Van den Brink, M
Hoogeman, MS
Meinders, J
Lebesque, JV
Citation: Gj. Meijer et al., Dose-wall histograms and normalized dose-surface histograms for the rectum: A new method to analyze the dose distribution over the rectum in conformal radiotherapy, INT J RAD O, 45(4), 1999, pp. 1073-1080
Authors:
Brugmans, MJP
van der Horst, A
Lebesque, JV
Mijnheer, BJ
Citation: Mjp. Brugmans et al., Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: A dosimetric study, INT J RAD O, 43(4), 1999, pp. 893-904
Citation: Jcm. Theuws et al., Prediction of overall pulmonary function loss in relation to the 3D dose distribution for patients with breast cancer and malignant lymphoma - Reply, RADIOTH ONC, 52(2), 1999, pp. 196-197
Authors:
Remeijer, P
Rasch, C
Lebesque, JV
van Herk, M
Citation: P. Remeijer et al., A general methodology for three-dimensional analysis of variation in target volume delineation, MED PHYS, 26(6), 1999, pp. 931-940
Authors:
Theuws, JCM
Kwa, SLS
Wagenaar, AC
Seppenwoolde, Y
Boersma, LJ
Damen, EMF
Muller, SH
Baas, P
Lebesque, JV
Citation: Jcm. Theuws et al., Prediction of over-all pulmonary function loss in relation to the 3-D dosedistribution for patients with breast cancer and malignant lymphoma, RADIOTH ONC, 49(3), 1998, pp. 233-243
Citation: Jsa. Belderbos et al., Elective nodal irradiation in non-small cell lung cancer patients, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 99-102
Citation: Lj. Boersma et al., Toxicity and tolerance of thoracic radiotherapy: tools for evaluation and prediction of toxicity, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 163-168